Topics

Companies Related to "Acute Spinal Cord Injury Global Clinical Trials Review" [Most Relevant Company Matches] RSS

11:16 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "Acute Spinal Cord Injury Global Clinical Trials Review" found in our extensive corporate database of over 50,000 company records.

Showing "Acute Spinal Cord Injury Global Clinical Trials Review" Companies 1–25 of 10,000+

Extremely Relevant

SCT Spinal Cord Therapeutics GmbH

SCT Spinal Cord Therapeutics GmbH stands for pioneering the therapy of acute and chronic Spinal Cord Injuries (SCI) with its proprietary technology platform: the Regeneration Promoting Treatment (RPT). As first application of RPT SCT Spinal Cord Therapeutics GmbH is focusing on the clinical development of the Orphan Drug Cordaneurin for the treatment of acute SCI.


Neuraxo Biopharmaceuticals GmbH

Neuraxo Biopharmaceuticals, a German biopharmaceutical company stands for pioneering the therapy of acute and chronic Spinal Cord Injuries with its proprietary technology platform: the Regeneration Promoting Treatment (RPT). As a first clinical application of the RPT Neuraxo is focusing on the clinical development of Cordaneurin® - a drug for the treatment of acute Spinal Cord Injuries which rece...

DMC Rehabilitation Institute of Michigan

DMC’s Rehabilitation Institute of Michigan (RIM) is one of the nation’s largest freestanding rehabilitation hospitals specializing in rehabilitation medicine and research. RIM is known for its clinical expertise in spinal cord injury, brain injury, stroke, complex trauma and orthopedics. The Institute is home to many innovative programs, includin...


Remedy Pharmaceuticals, Inc.

Remedy Pharmaceuticals, Inc. is a clinical stage pharmaceutical company focused on the development and commercialization of small molecule drugs for acute central nervous system disorders including stroke, traumatic brain injury, and spinal cord injury. RP-1127 has not yet been approved for use by the FDA.

Proneuron Biotechnologies

Proneuron Biotechnologies is a biopharmaceutical company developing therapies for neurological disorders, including spinal cord injuries (SCI), brain trauma, and neurodegenerative diseases such as ALS, Huntington’s and Alzheimer’s diseases. The brain, spinal cord and optic nerves comprise the central nervous system (CNS) one of the most complex and enigmatic systems in nature. The CNS is respo...

Paralyzed Veterans of America 

Paralyzed Veterans of America is the only congressionally chartered veterans service organization dedicated solely for the benefit and representation of veterans with spinal cord injury or disease. For nearly 70 years, we have ensured that veterans have received the benefits earned through their service to our nation; monitored the...

Zynex, Inc.

Zynex, Inc. (founded in 1996) engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove™ for stroke and spinal cord injury (SCI) rehabilitation. Zynex's product lines are fully developed, FDA-cleare...

Disabled American Veterans and Paralyzed Veterans of America and Veterans of Foreign Wars

Paralyzed Veterans of America is the only congressionally chartered veterans service organization dedicated solely for the benefit and representation of veterans with spinal cord injury or disease. For nearly 70 years, Paralyzed Veterans has ensured that veterans have received the benefits earned through their service to our nation; monitore...

RNL Bio Co., Ltd

RNL Bio is a premier biotechnology company focused on the research and development of adult derived stem cell therapies. RNL has conducted two Phase II clinical trials for Buerger's Disease as well as Osteoarthritis and one phase I trial for spinal cord injury. RNL is a publically traded company listed in the Korean Stock Exchange (Code 003190) and is expanding its operations throughout the world....

Myomo, Inc.

Myomo, Inc. is a medical device company specializing in myoelectric orthotics for people with neurological disorders. The Company’s products help to restore function in individuals with neuromuscular conditions such as brachial plexus injury, traumatic brain injury, spinal cord injury, Multiple Sclerosis, ALS, and stroke.

Diacrin Incorporated

Diacrin is developing transplantable cells for the treatment of human diseases which are characterized by cell dysfunction or cell death and for which current therapies are either inadequate or nonexistent. Products under development for the treatment of neurological disorders include: NeuroCell(TM)-PD for Parkinson's disease and NeuroCell(TM)-HD for Huntington's dise...

Geron Corporation

Geron is developing first-in-class biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure and diabetes. The company is advancing an anti-cancer drug and a cancer vaccine that target the enzyme telomerase through multiple clinical trials in different cancers. For more information, visit ...

Zynex Inc.

Zynex, Inc. (founded in 1996) engineers, manufactures, markets and sells its own design of electrotherapy medical devices in two distinct markets: standard digital electrotherapy products for pain relief and pain management; and the NeuroMove(TM) for stroke and spinal cord injury rehabilitation. Zynex's product lines are fully developed, FDA-cleared, comme...

PathMaker Neurosystems Inc.

PathMaker Neurosystems Inc. is a clinical-stage neuromodulation company founded to commercialize recent breakthrough advances in the development and clinical application of trans-spinal direct current stimulation (tsDCS) for patients with neuromotor disorders. More than 27 million patients in the US and Europe suffer disabilities due to stroke, cerebral pa...

Beike Biotech Company Limited

Beike Biotechnology (http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for u...

Shenzhen Beike Biotechnology Co. Ltd.

Beike Biotechnology ( http://www.beikebiotech.com ) is China's leading biotechnology company. Its scientists have been focused on the development and commercialization of adult stem cell therapies since 1999. The company currently produces a full line of stem cell products from umbilical cord, cord blood, and bone marrow stem cells. Beike's unique processing technologies prepare the cells for ...

Neuron Therapeutics

Neuron Therapeutics, Inc. ("NTI") is a clinical-stage company developing unique therapies for the treatment of central nervous system (CNS) disorders through the application of proprietary pharmaceutical and drug delivery technologies. NTI is bringing these technologies to bear on the treatment of subarachnoid hemorrhage, stroke, spinal cord injury and traumatic brain injury. These conditions repr...

Proneuron Biotechnologies (Israel) Limited

Proneuron Biotechnologies is developing therapies for neurological, ophthalmologic and immune-related disorders such as spinal cord injuries, multiple sclerosis, glaucoma, Parkinson's disease and Alzheimer's diseases. The technology derives from research on key mechanisms in the dialogue between the nervous and immune systems originating from The Weizmann Institute of Science. Proneuron's novel st...

ParadigmHealth, Inc.

Founded in 1991, ParadigmHealth's mission is to achieve superior medical outcomes and lower costs for complex medical events. As the country's first and only expert clinical management system to focus solely on complex care, ParadigmHealth has managed over 30,000 complex cases, including high-risk neonates, acquired brain injury, spinal cord injury, multiple trauma, severe burn injury and other co...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases includi...

Christopher and Dana Reeve Foundation

The Christopher & Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, and to review the entire list of Quality of Life grant recipients, please visit our website at www.ChristopherReeve.org or call 800-225-0292.

Christopher Reeve Paralysis Foundation

The Christopher and Dana Reeve Foundation is dedicated to curing spinal cord injury by funding innovative research, and improving the quality of life for people living with paralysis through grants, information and advocacy. For more information, and to review the entire list of Quality of Life grant recipients, please visit our website at www.ChristopherReeve.org or call 800-225-0292.

Acorda Therapeutics, Inc.

Acorda Therapeutics is a biotechnology company developing therapies for multiple sclerosis, spinal cord injury and other nervous system disorders. The Company's marketed products include AMPYRA®(dalfampridine) Extended Release Tablets, 10 mg, a potassium channel blocker approved as a treatment to improve walking in patients with multiple sclerosis (MS); this w...

Shenzhen Beike Biotechnology Company, Ltd.

Shenzhen Beike Biotechnology Co., Ltd. is China's leading biotechnology company focusing on the production of adult stem cells for use in medical therapies. Headquartered in Shenzhen (near Hong Kong) with a flagship regenerative medicine facility at the China Medical City in Jiangsu province, Beike produces a full line of stem cell products derived from umbilical cord, cord blood and autologou...

Acorda Therapeutics

Acorda Therapeutics, Inc. was established in March 1995 to develop therapeutic products for spinal cord injury ("SCI") and other central nervous system disorders. Acorda is focusing its initial development efforts on a range of therapeutics for individuals with chronic, or long term, SCI. Currently, there is no therapy that improves neurological function in chronic SCI patients.However, Acorda's c...


More From BioPortfolio on "Acute Spinal Cord Injury Global Clinical Trials Review"

Quick Search

Corporate Database Quicklinks